Peng Tiffany Y, Ehrlich Samantha F, Crites Yvonne, Kitzmiller John L, Kuzniewicz Michael W, Hedderson Monique M, Ferrara Assiamira
Division of Research, Kaiser Permanente of Northern California, Oakland, CA.
Division of Research, Kaiser Permanente of Northern California, Oakland, CA; Department of Public Health, University of Tennessee Knoxville, Knoxville, TN.
Am J Obstet Gynecol. 2017 Feb;216(2):177.e1-177.e8. doi: 10.1016/j.ajog.2016.10.007. Epub 2016 Oct 15.
Despite concern for adverse perinatal outcomes in women with diabetes mellitus before pregnancy, recent data on the prevalence of pregestational type 1 and type 2 diabetes mellitus in the United States are lacking.
The purpose of this study was to estimate changes in the prevalence of overall pregestational diabetes mellitus (all types) and pregestational type 1 and type 2 diabetes mellitus and to estimate whether changes varied by race-ethnicity from 1996-2014.
We conducted a cohort study among 655,428 pregnancies at a Northern California integrated health delivery system from 1996-2014. Logistic regression analyses provided estimates of prevalence and trends.
The age-adjusted prevalence (per 100 deliveries) of overall pregestational diabetes mellitus increased from 1996-1999 to 2012-2014 (from 0.58 [95% confidence interval, 0.54-0.63] to 1.06 [95% confidence interval, 1.00-1.12]; P <.0001). Significant increases occurred in all racial-ethnic groups; the largest relative increase was among Hispanic women (121.8% [95% confidence interval, 84.4-166.7]); the smallest relative increase was among non-Hispanic white women (49.6% [95% confidence interval, 27.5-75.4]). The age-adjusted prevalence of pregestational type 1 and type 2 diabetes mellitus increased from 0.14 (95% confidence interval, 0.12-0.16) to 0.23 (95% confidence interval, 0.21-0.27; P <.0001) and from 0.42 (95% confidence interval, 0.38-0.46) to 0.78 (95% confidence interval, 0.73-0.83; P <.0001), respectively. The greatest relative increase in the prevalence of type 1 diabetes mellitus was in non-Hispanic white women (118.4% [95% confidence interval, 70.0-180.5]), who had the lowest increases in the prevalence of type 2 diabetes mellitus (13.6% [95% confidence interval, -8.0 to 40.1]). The greatest relative increase in the prevalence of type 2 diabetes mellitus was in Hispanic women (125.2% [95% confidence interval, 84.8-174.4]), followed by African American women (102.0% [95% confidence interval, 38.3-194.3]) and Asian women (93.3% [95% confidence interval, 48.9-150.9]).
The prevalence of overall pregestational diabetes mellitus and pregestational type 1 and type 2 diabetes mellitus increased from 1996-1999 to 2012-2014 and racial-ethnic disparities were observed, possibly because of differing prevalence of maternal obesity. Targeted prevention efforts, preconception care, and disease management strategies are needed to reduce the burden of diabetes mellitus and its sequelae.
尽管人们担心孕前患有糖尿病的女性会出现不良围产期结局,但美国目前缺乏关于孕前1型和2型糖尿病患病率的最新数据。
本研究旨在评估1996年至2014年间孕前糖尿病(所有类型)、孕前1型糖尿病和孕前2型糖尿病患病率的变化,并评估这些变化是否因种族/族裔而异。
我们在1996年至2014年间对北加利福尼亚综合医疗服务系统中的655428例妊娠进行了一项队列研究。逻辑回归分析提供了患病率和趋势的估计值。
1996 - 1999年至2012 - 2014年期间,年龄调整后的孕前糖尿病总体患病率(每100例分娩)有所上升(从0.58 [95%置信区间,0.54 - 0.63]升至1.06 [95%置信区间,1.00 - 1.12];P <.0001)。所有种族/族裔群体均出现显著上升;相对增幅最大的是西班牙裔女性(121.8% [95%置信区间,84.4 - 166.7]);相对增幅最小的是非西班牙裔白人女性(49.6% [95%置信区间,27.5 - 75.4])。孕前1型和2型糖尿病的年龄调整患病率分别从0.14(95%置信区间,0.12 - 0.16)升至0.23(95%置信区间,0.21 - 0.27;P <.0001),以及从0.42(95%置信区间,0.38 - 0.46)升至0.78(95%置信区间,0.73 - 0.83;P <.0001)。1型糖尿病患病率相对增幅最大的是非西班牙裔白人女性(118.4% [95%置信区间,70.0 - 180.5]),而她们的2型糖尿病患病率增幅最小(13.6% [95%置信区间, - 8.0至40.1])。2型糖尿病患病率相对增幅最大的是西班牙裔女性(125.2% [95%置信区间,84.8 - 174.4]),其次是非洲裔美国女性(102.0% [95%置信区间,38.3 - 194.3])和亚洲女性(93.3% [95%置信区间,48.9 - 150.9])。
1996年至2014年间,孕前糖尿病总体患病率、孕前1型和2型糖尿病患病率均有所上升,且观察到种族/族裔差异,这可能是由于孕产妇肥胖患病率不同所致。需要有针对性的预防措施、孕前保健和疾病管理策略,以减轻糖尿病及其后遗症的负担。